Transaction · 0001231919-26-001107
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014, L.P.
MPM BioVentures 2014, L.P., 10%, reported an open-market or private sale at Entrada Therapeutics, Inc. involving 21623.000000 shares for an estimated $158712.82. Reported holdings after the transaction were 4359439.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Open-market sellSEC transaction code S10%
- Trade date
- Aug 24, 2026
- Filing date
- Aug 27, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 4,381,062 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TRDA price since this filing
Daily closing prices, with the filing date and available return windowsTRDA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -1.4%30d -15.3%90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001231919-26-001107 Common Stock
- Transaction date
- Aug 24, 2026 Filed Aug 27, 2026, 01:28 AM · 3d delay
- Shares
- 21,623 sh $7.34 per share
- Estimated value
- -$158k Computed from shares × price
- Holdings after
- 4,359,439 sh Indirect · See Footnote
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling
Filing-only score
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
Neutral filing signal
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector No10% YesOther No
Footnotes & amended
- F1
The shares were sold as follows: 9,819 by MPM BioVentures 2014, L.P. ("BV 2014"), 655 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)"), 338 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"), 1…
- F2
Price represents the weighted average sale price of the shares sold. The sale price ranged from $7.0852 to $7.58 per share. Upon request by the Commission staff, the Issuer, or a security holder of th…
- F3
The shares are held as follows: 1,979,549 by BV 2014, 132,032 by BV 2014(B), 68,137 by AM BV2014, 2,031,644 by BV 2018, 107,980 by BV 2018(B) and 40,097 by AM BV2018.
- F4
Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
- F5
The shares were sold as follows: 12,043 by BV 2014, 803 by BV 2014(B), 415 by AM BV2014, 12,360 by BV 2018, 657 by BV 2018(B) and 244 by AM BV2018.
- F6
Price represents the weighted average sale price of the shares sold. The sale price ranged from $7.28 to $7.6421 per share. Upon request by the Commission staff, the Issuer, or a security holder of th…
- F7
The shares are held as follows: 1,967,506 by BV 2014, 131,229 by BV 2014(B), 67,722 by AM BV2014, 2,019,284 by BV 2018, 107,323 by BV 2018(B) and 39,853 by AM BV2018.
- F8
The shares were sold as follows: 6,615 by BV 2014, 441 by BV 2014(B), 228 by AM BV2014, 6,790 by BV 2018, 361 by BV 2018(B) and 134 by AM BV2018.
- F9
Price represents the weighted average sale price of the shares sold. The sale price ranged from $6.97 to $7.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the…
- F10
The shares are held as follows: 1,960,891 by BV 2014, 130,788 by BV 2014(B), 67,494 by AM BV2014, 2,012,494 by BV 2018, 106,962 by BV 2018(B) and 39,719 by AM BV2018.
Related transactions
Same SEC filing0 other transactions
Recent company activity
TRDA0 recent txs